Exhibit 10.35(b)
AMENDMENT 2008-1
TO THE
JOHN B. HENNEMAN, III
PERFORMANCE STOCK AGREEMENT
DATED AS OF APRIL 2, 2007
     THIS AMENDMENT, dated as of January 2, 2008, between Integra LifeSciences
Holdings Corporation, a Delaware Corporation (the “Company”) and John B.
Henneman, III (“Executive”).
RECITALS
     WHEREAS, pursuant to a Performance Stock Agreement, dated as of April 2,
2007, (the “Stock Agreement”) the Company granted to Executive an aggregate of
4,366 shares of common stock of the Company under the Integra LifeSciences
Holdings Corporation 2003 Equity Incentive Plan, subject to certain performance
goals and other restrictions;
     WHEREAS, the Company and Executive mutually desire to amend the Stock
Agreement to comply with the requirements of section 409A of the Internal
Revenue Code of 1986, as amended and the final regulations issued thereunder;
and
     WHEREAS, Section 4.6 of the Stock Agreement provides that the Stock
Agreement may be amended pursuant to a written agreement between the Company and
Executive.
     NOW, THEREFORE, the Company and Executive hereby agree that, effective
January 2, 2008, the Stock Agreement shall be amended as follows:
     1. The first sentence of Section 3.2 of the Stock Agreement is hereby
amended in its entirety to read as follows:
“If the Participant has a Termination of Service on account of a termination by
the Company without Cause, Good Reason, death or Disability prior to the end of
the Performance Period, the Shares represented by the Performance Stock shall be
issued to the Participant (or the Participant’s beneficiary, in the case of
death) within sixty (60) days following the Participant’s Termination of
Service.”
     2. The first sentence of Section 3.3 of the Stock Agreement is hereby
amended in its entirety to read as follows:
“Except as provided in Section 3.2 above upon an acceleration event, after the
end of the Performance Period, and subject to a determination of the Committee
that the applicable Performance Goals have been met, the Shares represented by
the Performance Stock for which the relevant goals have been attained shall be
issued to the Participant or his legal representative on or after January 1,
2009 but prior to March 15, 2009. As soon as practicable thereafter or following
an acceleration event described in Section 3.2 of this Award Agreement, the
Company shall issue certificates evidencing the Shares represented by the
Performance Stock and

 

--------------------------------------------------------------------------------

 

deliver such certificates to the Participant or his legal representative, free
from any restrictions; provided, however, such Shares shall be subject to any
such restrictions and conditions as required pursuant to Section 4.5 of the
Award Agreement and those that the Company imposes on its employees in general
with respect to selling its Shares.”
     3. A new Section 4.8 is hereby added to the Stock Agreement to read in its
entirety as follows:
“Section 4.8. Section 409A. This Agreement is intended to comply with the
requirements of section 409A of the Internal Revenue Code of 1986, as amended
(the ‘Code’), and specifically, with the short-term deferral exemption of
section 409A. Notwithstanding any provision in the Agreement to the contrary, if
a payment is deemed as deferred compensation subject to the requirements of
section 409A of the Code, such payment may only be made under the Agreement upon
an event and in a manner permitted by section 409A of the Code. If a payment is
not made by the designated payment date under the Agreement, the payment shall
be made by December 31 of the calendar year in which the designated date occurs.
All payments to be made upon a Termination of Employment under this Agreement
may only be made upon a ‘separation from service’ under section 409A of the
Code. In no event may the Participant, directly or indirectly, designate the
calendar year of payment.”
     4. In all respects not modified by this Amendment 2008-1, the Stock
Agreement is hereby ratified and confirmed.
     IN WITNESS WHEREOF, the Company and Executive agree to the terms of the
foregoing Amendment 2008-1, effective as of the date set forth above.

            INTEGRA LIFESCIENCES
HOLDINGS CORPORATION
      By:   /s/ Stuart M. Essig         Name:   Stuart M. Essig        Title:  
President and Chief Executive Officer        EXECUTIVE
        /s/ John B. Henneman, III         John B. Henneman, III           

2